These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1742082)
1. Intracellular metabolism of 3'-azidothymidine in isolated human peripheral blood mononuclear cells. Törnevik Y; Jacobsson B; Britton S; Eriksson S AIDS Res Hum Retroviruses; 1991 Sep; 7(9):751-9. PubMed ID: 1742082 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells. Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641 [TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT). Periclou AP; Nandy P; Avramis VI In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870 [TBL] [Abstract][Full Text] [Related]
4. Comparison of rates of intracellular metabolism of zidovudine in human and primate peripheral blood mononuclear cells. Qian M; Chandrasena G; Ho RJ; Unadkat JD Antimicrob Agents Chemother; 1994 Oct; 38(10):2398-403. PubMed ID: 7840577 [TBL] [Abstract][Full Text] [Related]
5. Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine). Balzarini J; Naesens L; Aquaro S; Knispel T; Perno C; De Clercq E; Meier C Mol Pharmacol; 1999 Dec; 56(6):1354-61. PubMed ID: 10570065 [TBL] [Abstract][Full Text] [Related]
6. Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs. Zhu Z; Schinazi RF; Chu CK; Williams GJ; Colby CB; Sommadossi JP Mol Pharmacol; 1990 Dec; 38(6):929-38. PubMed ID: 2250666 [TBL] [Abstract][Full Text] [Related]
7. Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM). Fridland A; Connelly MC; Ashmun R Mol Pharmacol; 1990 May; 37(5):665-70. PubMed ID: 2338944 [TBL] [Abstract][Full Text] [Related]
8. A method for the quantification of intracellular zidovudine nucleotides. Kuster H; Vogt M; Joos B; Nadai V; Lüthy R J Infect Dis; 1991 Oct; 164(4):773-6. PubMed ID: 1894938 [TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive method to quantify intracellular zidovudine mono-, di- and triphosphate concentrations in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry. Kinai E; Gatanaga H; Kikuchi Y; Oka S; Kato S J Mass Spectrom; 2015 Jun; 50(6):783-91. PubMed ID: 26169132 [TBL] [Abstract][Full Text] [Related]
10. A sensitive nonisotopic method for the determination of intracellular azidothymidine 5'-mono-, 5'-di-, and 5'-triphosphate. Toyoshima T; Kimura S; Muramatsu S; Takahagi H; Shimada K Anal Biochem; 1991 Aug; 196(2):302-7. PubMed ID: 1776679 [TBL] [Abstract][Full Text] [Related]
11. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection. Avramis VI; Kwock R; Solorzano MM; Gomperts E J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464 [TBL] [Abstract][Full Text] [Related]
12. 3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptase. Dharmasena S; Pongracz Z; Arnold E; Sarafianos SG; Parniak MA Biochemistry; 2007 Jan; 46(3):828-36. PubMed ID: 17223704 [TBL] [Abstract][Full Text] [Related]
13. Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure. Slusher JT; Kuwahara SK; Hamzeh FM; Lewis LD; Kornhauser DM; Lietman PS Antimicrob Agents Chemother; 1992 Nov; 36(11):2473-7. PubMed ID: 1489190 [TBL] [Abstract][Full Text] [Related]
14. Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP. Ostermann N; Lavie A; Padiyar S; Brundiers R; Veit T; Reinstein J; Goody RS; Konrad M; Schlichting I J Mol Biol; 2000 Nov; 304(1):43-53. PubMed ID: 11071809 [TBL] [Abstract][Full Text] [Related]
15. Improved method to quantify intracellular zidovudine mono- and triphosphate in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry. Compain S; Durand-Gasselin L; Grassi J; Benech H J Mass Spectrom; 2007 Mar; 42(3):389-404. PubMed ID: 17238240 [TBL] [Abstract][Full Text] [Related]
16. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8. Darnowski JW; Goulette FA Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity. McKee EE; Bentley AT; Hatch M; Gingerich J; Susan-Resiga D Cardiovasc Toxicol; 2004; 4(2):155-67. PubMed ID: 15371631 [TBL] [Abstract][Full Text] [Related]
18. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance. Kerr SG; Anderson KS Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478 [TBL] [Abstract][Full Text] [Related]